Pharma Archives - Life Sciences Times

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

June 3, 2025

THIS WEEK'S STORIES

Enveric Biosciences Secures U.S. Patent for Novel Melatonin Receptor-Targeting Compounds

June 3, 2025

RevBio Launches UK Clinical Trial for Regenerative Bone Adhesive in Cranial Surgery

May 30, 2025

Rad AI Appoints Demetri Giannikopoulos as Chief Growth Officer to Expand AI Footprint in U.S. Radiology

June 2, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

Acerand Therapeutics Begins First-in-Human Trial of ACE-232 for Advanced Prostate Cancer

Seyltx Reports Promising Preclinical Results for Chronic Cough Drug Ifenprodil Ahead of Phase 2 Trials

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

CinDome Pharma Begins Phase 2 Trial of Deudomperidone for Idiopathic Gastroparesis

Most Read

IDEXX Launches In-Clinic Cortisol Test to Help Veterinarians Diagnose Canine Endocrine Disorders

Charter Next Generation Names Lisa Alteri as Chief Operating Officer to Drive Operational Strategy and Growth

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

Genetic Marker Linked to Immunotherapy Resistance in Deadly Skin Cancer, NYU Study Finds

EDITOR PICKS

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

THIS WEEK'S STORIES

Enveric Biosciences Secures U.S. Patent for Novel Melatonin Receptor-Targeting Compounds

RevBio Launches UK Clinical Trial for Regenerative Bone Adhesive in Cranial Surgery

Rad AI Appoints Demetri Giannikopoulos as Chief Growth Officer to Expand AI Footprint in U.S. Radiology

POPULAR CATEGORY

ABOUT US

FOLLOW US